Andreea Anița died on March 3, 11 years after receiving her diagnosis ...

Cancer drug pulled market as Ipsen removes Tazverik from the U.S. due to secondary blood cancer risks reported in clinical trials.

Synovial sarcoma is a rare, aggressive malignancy with deceptive benign presentation, complicating diagnosis and delaying treatment. Molecular confirmation of SS18-SSX fusion genes is crucial for ...

Synovial sarcoma, a rare cancer, thrives on glutamine. Blocking its nutrient supply with the drug V9302 stops tumor growth, offering a new way to treat the disease.

A collaborative research team, led by scientists at VCU Massey Comprehensive Cancer Center and Huntsman Cancer Institute at the University of Utah, has identified a targeted drug that could ...

Botensilimab and balstilimab combination therapy is approved in France for ovarian cancers and soft tissue sarcomas under the AAC framework. The therapy, initially for microsatellite-stable metastatic ...

"Ofelia left us with a lot of light, a lot of strength," said Reyna Torres, Mexican consul general in Chicago, after the service in Montclare for Ofelia Giselle Torres Hidalgo, 16, who died Feb. 13 ...

If you or someone you love is facing a mouth cancer diagnosis, MSK experts can help. If you want to learn about surgeries to ...

Iovance Biotherapeutics shares rose after the company shared positive trial results from a treatment designed for soft tissue cancer. The stock gained 26% to $3.65 Tuesday. Shares are still down 32% ...